FKBP5 and depressive symptom measurement: This study aimed to determine the changes in the expression of Fkbp5 and its validated regulator, miRNA-511-5p, during short- and long-term lithium treatment in four brain regions: the hypothalamus, hippocampus, pituitary, and frontal cortex in a chronic mild stress rat model of depression.